Search results
Britain Poised to Offer Eli Lilly’s Weight-Loss Drug to Patients
Bloomberg· 5 hours agoEli Lilly & Co.’s Mounjaro is being recommended for weight loss for some UK patients with obesity,...
Eli Lilly and Company (NYSE:LLY) Major Shareholder Lilly Endowment Inc Sells 22,206 Shares of Stock
ETF DAILY NEWS· 12 hours agoEli Lilly and Company (NYSE:LLY – Get Free Report) major shareholder Lilly Endowment Inc sold 22,206 shares of the business’s stock in ...
Beyond The Nvidia Juggernaut: 2 Chip Giants, 2 Drugmakers In Spotlight
Investor's Business Daily· 1 hour agoTop drugmakers Eli Lilly and Novo Nordisk also make this list of top growth stocks. Eli Lilly now...
Barclays bullish on Eli Lilly stock with positive outlook By Investing.com
Investing.com· 1 day agoOn Monday, Barclays expressed a positive stance on Eli Lilly (NYSE:LLY) stock, maintaining an...
Eli Lilly Beefs Up Neuro Pipeline With Addition Of Preclinical ALS, Dementia Prospect
Benzinga· 20 hours agoOn Monday, privately held QurAlis Corporation entered into an exclusive license agreement with Eli ...
Eli Lilly executive sells over $600k in company stock By Investing.com
Investing.com· 20 hours agoEli Lilly & Co (NYSE:LLY) executive Donald A. Zakrowski, who serves as the Senior Vice President of...
Is Eli Lilly Stock A Buy On A Recent Crohn's Disease-Related Rally?
Investor's Business Daily· 5 days agoEli Lilly stock rocketed and broke out earlier this month after unveiling promising results for its...
Eli Lilly and Company Lima Stock Price Today | NYSE LLY Live Ticker - Investing.com
Investing.com· 10 hours agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for ...
The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy.
Motley Fool via Yahoo Finance· 1 day agoEli Lilly and Novo Nordisk are, so far, the kings of the weight-loss gold rush. Thanks to their...
Eli Lilly's Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030,...
Business Insider via Yahoo Finance· 2 days agoZepbound is Eli Lilly's new weight-loss drug.Brendan McDermid/Reuters The anti-obesity drug market...